| Dr Ansu Mathew Punnoose, DO | |
|
8175 Westside Blvd Ste D, Fulton, MD 20759-2708 | |
| (240) 580-2650 | |
| (240) 580-2651 |
| Full Name | Dr Ansu Mathew Punnoose |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 8175 Westside Blvd Ste D, Fulton, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235496233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H0079559 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Healthcare Pc | 3779723309 | 131 |
News Archive
Patients with psoriasis, an autoimmune skin disorder, often have cardiovascular disorders as well. Hence, it is important for patients and clinicians to understand how treatments for psoriasis may influence cardiovascular disease risks.
Efforts to contain the novel coronavirus have caused lockdowns and school closures around the world. These efforts and policies have unfortunately cut off many children from valuable resources such as the opportunity for exercise, access to clean water and food, learning, and socialization.
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
› Verified 6 days ago
| Entity Name | Capital Healthcare Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811239627 PECOS PAC ID: 3779723309 Enrollment ID: O20170918001050 |
News Archive
Patients with psoriasis, an autoimmune skin disorder, often have cardiovascular disorders as well. Hence, it is important for patients and clinicians to understand how treatments for psoriasis may influence cardiovascular disease risks.
Efforts to contain the novel coronavirus have caused lockdowns and school closures around the world. These efforts and policies have unfortunately cut off many children from valuable resources such as the opportunity for exercise, access to clean water and food, learning, and socialization.
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ansu Mathew Punnoose, DO 8175 Westside Blvd Ste D, Fulton, MD 20759-2708 Ph: (240) 580-2650 | Dr Ansu Mathew Punnoose, DO 8175 Westside Blvd Ste D, Fulton, MD 20759-2708 Ph: (240) 580-2650 |
News Archive
Patients with psoriasis, an autoimmune skin disorder, often have cardiovascular disorders as well. Hence, it is important for patients and clinicians to understand how treatments for psoriasis may influence cardiovascular disease risks.
Efforts to contain the novel coronavirus have caused lockdowns and school closures around the world. These efforts and policies have unfortunately cut off many children from valuable resources such as the opportunity for exercise, access to clean water and food, learning, and socialization.
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
› Verified 6 days ago
Samantha M Swords, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8115 Maple Lawn Blvd, Fulton, MD 20759 Phone: 240-459-1800 | |
Arfassa Shiferaw, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8115 Maple Lawn Blvd Ste 140, Fulton, MD 20759 Phone: 240-459-1800 | |
Loretta Sutphin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8115 Maple Lawn Blvd Ste 140, Fulton, MD 20759 Phone: 240-459-1800 | |
Ali Seyed Sajjadi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8115 Maple Lawn Blvd Ste 140, Fulton, MD 20759 Phone: 240-459-1830 |